Posts Tagged ‘Researchers’

Georgetown University and Urban Institute Researchers Release State-by-State Analysis on How the Affordable Care Act Will Create Opportunities for More Entrepreneurs











Washington, D.C (PRWEB) June 04, 2013

A team of nationally recognized researchers estimate that the number of self-employed entrepreneurs will be 1.5 million higher in 2014 because of the new health insurance options created by the Affordable Care Act (ACA). The Robert Wood Johnson Foundation sponsored report was coauthored by Georgetown University’s Center on Health Insurance Reforms and the Urban Institute.

“Far too many people have had their dream of launching their own business delayed or denied because they couldn’t afford to give up the security of good health insurance,” said Sabrina Corlette, co-author of the report and director of the Georgetown University Center on Health Insurance Reforms. “That’s all about to change when the Affordable Care Act starts offering high-quality health insurance options that aren’t tied to employment.”

The researchers found the impact of the ACA on entrepreneurship will vary state by state, depending on the insurance market reforms states may already have in place. For example, they estimate an increase of 124,000 newly self-employed in Texas, 72,000 in Florida, 67,000 in Ohio and 60,000 in Pennsylvania because the ACA’s reforms will improve individual’s access to high quality health insurance that isn’t tied to their jobs. Massachusetts, however, will see no measurable change because many of the ACA’s reforms are already in place.

Provisions of the new health law that may encourage more people to start their own business include:


No applicant can be turned down because of a preexisting condition.

Individuals cannot be charged higher premiums because of their health status.

Insurers must offer plans with a comprehensive set of essential health benefits.

Tax credits to help low- or moderate- individuals and families will reduce premium costs.

Medicaid expansion, in some states, will provide coverage for those with the lowest incomes.

The research was funded by Robert Wood Johnson Foundation and published by the Center on Health Insurance Reforms (CHIR) and the Urban Institute. CHIR is composed of a team of nationally recognized experts on private health insurance and health reform. For more on the center’s work, please see our website and blog.











Attachments


















Vocus©Copyright 1997-

, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.









Mary Pat Higley: Pharma Companies Partner with Academic Researchers










New York, NY (PRWEB) September 23, 2012

According to U.S. Politics Today, drug developers and academic medical centers are working together to achieve future pharmaceutical breakthroughs. This partnership has, according to the article, the potential of changing the way that drugs are researched and developed. Mary Pat Higley, a clinical pharmacist and leader in the pharmaceutical field, believes that the pairing of pharmaceutical companies and academic facilities can improve the drug development process.

The article’s insight is gleaned from a panel of professionals called to order by the Tufts Center for the Study of Drug Development. During a roundtable event, the participants on the panel noted that today’s drug developers face two major issues. First, they need to update their business models in order to produce cost-effective products quickly. Second, they need to reexamine and adjust their research processes to create a more effective research and development pipeline.

Professor and Director of the Center for the Study of Drug Development Kenneth Kaitin comments: “The research complexities associated with the most challenging diseases and medical conditions means that few companies have the resources required to discover new molecules and then take them through clinical development and, ultimately, product launch. They are finding, however, that academic medical centers can provide a valuable way to bridge the gap between discovery and clinical development.”

Mary Pat Higley believes that such a partnership can create a more favorable environment for research and development, and lead to better drug production.

“Drug developers need to not only develop new drugs to treat diseases,” asserts Mary Pat Higley, “but to also carry out well-designed studies to test the effectiveness of these drugs on appropriate patient populations. Large academic centers have access to large populations of patients and are often regional centers for referrals. They also have known medical histories, as compared to small research facilities that don’t have access to the full medical record. Knowing extensive medical histories allows them to better screen and match the patients to the protocol criteria. This allows for clinical trials with complete information and clean data and results. Slow IRBs and difficulty getting studies through contracts and grants at large institutions have been obstacles to pharmaceutical companies that are anxious to get their clinical trials completed quickly and their drugs approved and on the market.”

ABOUT:

Mary Pat Higley is a clinical research professional who has developed a noteworthy career by combining her scientific knowledge with her business insight. With over three decades of experience, Mary Pat Higley has built a professional acumen that includes clinical pharmacy, project marketing, sales and marketing, and clinical research. Mary Pat Higley is committed to enhancing patient care and assisting with the improvement of national health. To achieve these goals, she has become a member of the Association of Clinical Research Professionals.






















Vocus©Copyright 1997-

, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.









More Small Business Press Releases